Unmet needs in current clinical practice for insulinoma: Lessons from nationwide studies in Japan.
J Diabetes Investig · 2022
Last updated 2026-05-28| Journal | J Diabetes Investig, 2022 |
|---|---|
| Citations | 9 |
| Relative citation ratio | 1.27 |
| NIH percentile | 59 |
| Molecules | — |
Abstract
Unmet clinical needs for the management of insulinoma include a low proportion of patients having surgical treatment, postoperative diabetes mellitus, and residual hypoglycemia. Glucagon-like peptide-1 (GLP-1) receptor-targeted imaging such as that using [ F]FB(ePEG12)12-exendin-4 positron emission tomography (PET) is promising and may fill unmet clinical needs.
Verbatim abstract via PubMed 34863032 ↗